Brenda Sandmaier MD

Cancer , Therapy , Outcome (Survival) , Longitudinal Studies , Clinical Trials , Drug Development/Application , Imaging , Antibodies , Hematopoiesis , Translation , Data Management/Integration , Multivariate Analysis , Immunology , Pathology


Dr. Sandmaier is interested in stem cell engraftment in MHC-matched and mismatched transplants. In addition, she also focuses on the development of nonmyeloablative conditioning regimens.


Fred Hutch Clinical Research Professor
UW Medicine Medical Oncology Professor